Fatty Acid Transduction of Nitric Oxide Signaling. Cyclooxygenases, Lipoxygenases and Nitro-Fatty Acids.

Nitric Oxide

Volumn , Issue , 2010, Pages 391-414

  Cole, Marsha P ^a   Freeman, Bruce A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882535837     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-373866-0.00011-3     Document Type: Chapter

References (170)

1. Akarasereenont P., Mitchell J.A., Bakhle Y.S., Thiemermann C., Vane J.R. Comparison of the induction of cyclooxygenase and nitric oxide synthase by endotoxin in endothelial cells and macrophages. Eur. J. Pharmacol. 1995, 273:121-128.
2. Akerfelt M., Trouillet D., Mezger V., Sistonen L. Heat shock factors at a crossroad between stress and development. Ann. N. Y. Acad. Sci. 2007, 1113:15-27.
3. Alonso-Galicia M., Drummond H.A., Reddy K.K., Falck J.R., Roman R.J. Inhibition of 20-HETE production contributes to the vascular responses to nitric oxide. Hypertension 1997, 29:320-325.
4. Baker P.R., Lin Y., Schopfer F.J., Woodcock S.R., Groeger A.L., Batthyany C., Sweeney S., Long M.H., Iles K.E., Baker L.M.S., Branchaud B.P., Chen Y.E., Freeman B.A. Fatty acid transduction of nitric oxide signaling: multiple nitrated unsaturated fatty acid derivatives exist in human blood and urine and serve as endogenous PPAR ligands. J. Biol. Chem. 2005, 280:42464-42475.
5. Baker P.R., Schopfer F.J., O'Donnell V.B., Freeman B.A. Convergence of nitric oxide and lipid signaling: anti-inflammatory nitro-fatty acids. Free Radic. Biol. Med. 2009, 46:989-1003.
6. Baker P.R., Schopfer F.J., Sweeney S., Freeman B.A. Red cell membrane and plasma linoleic acid nitration products: synthesis, clinical identification, and quantitation. Proc. Natl. Acad. Sci. USA 2004, 101:11577-11582.
7. Balazy M. Metabolism of 5,6-epoxyeicosatrienoic acid by the human platelet. Formation of novel thromboxane analogs. J. Biol. Chem. 1991, 266:23561-23567.
8. Batthyany C., Schopfer F.J., Baker P.R.S., Duran R., Baker L.M.S., Huang Y., Cervenansky C., Branchaud B.P., Freeman B.A. Reversible post-translational modification of proteins by nitrated fatty acids in vivo. J. Biol. Chem. 2006, 281:20450-20463.
9. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA 1990, 87:1620-1624.
10. Belkner J., Stender H., Kuhn H. The rabbit 15-lipoxygenase preferentially oxygenates LDL cholesterol esters, and this reaction does not require vitamin E. J. Biol. Chem. 1998, 273:23225-23232.
11. Bevan J.A., Laher I. Pressure and flow-dependent vascular tone. FASEB J. 1991, 5:2267-2273.
12. Bocan T.M., Rosebury W.S., Mueller S.B., Kuchera S., Welch K., Daugherty A., Cornicelli J.A. A specific 15-lipoxygenase inhibitor limits the progression and monocyte-macrophage enrichment of hypercholesterolemia-induced atherosclerosis in the rabbit. Atherosclerosis 1998, 136:203-216.
13. Brune B., Ullrich V. 12-hydroperoxyeicosatetraenoic acid inhibits main platelet functions by activation of soluble guanylate cyclase. Mol. Pharmacol. 1991, 39:671-678.
14. Campbell W.B., Gebremedhin D., Pratt P.F., Harder D.R. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ. Res. 1996, 78:415-423.
15. Capdevila J.H., Falck J.R., Estabrook R.W. Cytochrome P450 and the arachidonate cascade. FASEB J. 1992, 6:731-736.
16. Clark S.R., Anning P.B., Coffey M.J., Roberts A.G., Marnett L.J., O'Donnell V.B. Depletion of iNOS-derived nitric oxide by prostaglandin H synthase-2 in inflammation-activated J774.2 macrophages through lipohydroperoxidase turnover. Biochem. J. 2005, 385:815-821.
17. Coffey M.J., Natarajan R., Chumley P.H., Coles B., Thimmalapura P.R., Nowell M., Kuhn H., Lewis M.J., Freeman B.A., O'Donnell V.B. Catalytic consumption of nitric oxide by 12/15- lipoxygenase: inhibition of monocyte soluble guanylate cyclase activation. Proc. Natl. Acad. Sci. USA 2001, 98:8006-8011.
18. Coffey M.J., Phare S.M., Peters-Golden M. Prolonged exposure to lipopolysaccharide inhibits macrophage 5-lipoxygenase metabolism via induction of nitric oxide synthesis. J. Immunol. 2000, 165:3592-3598.
19. Coffey M.J., Phare S.M., Peters-Golden M. Interaction between nitric oxide, reactive oxygen intermediates, and peroxynitrite in the regulation of 5-lipoxygenase metabolism. Biochim. Biophys. Acta. 2002, 1584:81-90.
20. Coles B., Bloodsworth A., Clark S.R., Lewis M.J., Cross A.R., Freeman B.A., O'Donnell V.B. Nitrolinoleate inhibits superoxide generation, degranulation, and integrin expression by human neutrophils: novel antiinflammatory properties of nitric oxide-derived reactive species in vascular cells. Circ. Res. 2002, 91:375-381.
21. Coles B., Bloodsworth A., Eiserich J.P., Coffey M.J., McLoughlin R.M., Giddings J.C., Lewis M.J., Haslam R.J., Freeman B.A., O'Donnell V.B. Nitrolinoleate inhibits platelet activation by attenuating calcium mobilization and inducing phosphorylation of vasodilator-stimulated phosphoprotein through elevation of cAMP. J. Biol. Chem. 2002, 277:5832-5840.
22. Cui T., Schopfer F.J., Zhang J., Chen K., Ichikawa T., Baker P.R., Batthyany C., Chacko B.K., Feng X., Patel R.P., Agarwal A., Freeman B.A., Chen Y.E. Nitrated fatty acids: Endogenous anti-inflammatory signaling mediators. J. Biol. Chem. 2006, 281:35686-35698.
23. Curtis J.F., Reddy N.G., Mason R.P., Kalyanaraman B., Eling T.E. Nitric oxide: a prostaglandin H synthase 1 and 2 reducing cosubstrate that does not stimulate cyclooxygenase activity or prostaglandin H synthase expression in murine macrophages. Arch. Biochem. Biophys. 1996, 335:369-376.
24. Cyrus T., Witztum J.L., Rader D.J., Tangirala R., Fazio S., Linton M.F., Funk C.D. Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice. J. Clin. Invest. 1999, 103:1597-1604.
25. Davidge S.T., Baker P.N., Laughlin M.K., Roberts J.M. Nitric oxide produced by endothelial cells increases production of eicosanoids through activation of prostaglandin H synthase. Circ. Res. 1995, 77:274-283.
26. Deeb R.S., Shen H., Gamss C., Gavrilova T., Summers B.D., Kraemer R., Hao G., Gross S.S., Laine M., Maeda N., Hajjar D.P., Upmacis R.K. Inducible nitric oxide synthase mediates prostaglandin h2 synthase nitration and suppresses eicosanoid production. Am. J. Pathol. 2006, 168:349-362.
27. Denicola A., Souza J.M., Radi R. Diffusion of peroxynitrite across erythrocyte membranes. Proc. Natl. Acad. Sci. USA 1998, 95:3566-3571.
28. DeWitt D.L. Prostaglandin endoperoxide synthase: regulation of enzyme expression. Biochim. Biophys. Acta. 1991, 1083:121-134.
29. Donato M.T., Guillen M.I., Jover R., Castell J.V., Gomez-Lechon M.J. Nitric oxide-mediated inhibition of cytochrome P450 by interferon-gamma in human hepatocytes. J. Pharmacol. Exp. Ther. 1997, 281:484-490.
30. Dulak J., Deshane J., Jozkowicz A., Agarwal A. Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis. Circulation 2008, 117:231-241.
31. Eum H.A., Yeom D.H., Lee S.M. Role of nitric oxide in the inhibition of liver cytochrome P450 during sepsis. Nitric Oxide 2006, 15:423-431.
32. Fleming I. Cytochrome p450 and vascular homeostasis. Circ. Res. 2001, 89:753-762.
33. Folcik V.A., Nivar-Aristy R.A., Krajewski L.P., Cathcart M.K. Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques. J. Clin. Invest. 1995, 96:504-510.
34. Ford-Hutchinson A.W., Gresser M., Young R.N. 5-Lipoxygenase. Annu. Rev. Biochem. 1994, 63:383-417.
35. Freeman B.A., Baker P.R., Schopfer F.J., Woodcock S.R., Napolitano A., d'Ischia M. Nitro-fatty acid formation and signaling. J. Biol. Chem. 2008, 283:15515-15519.
36. Galpin J.R., Veldink G.A., Vliegenthart J.F., Boldingh J. The interaction of nitric oxide with soybean lipoxygenase-1. Biochim. Biophys. Acta. 1978, 536:356-362.
37. George J., Afek A., Shaish A., Levkovitz H., Bloom N., Cyrus T., Zhao L., Funk C.D., Sigal E., Harats D. 12/15-Lipoxygenase gene disruption attenuates atherogenesis in LDL receptor-deficient mice. Circulation 2001, 104:1646-1650.
38. Gergel D., Misik V., Riesz P., Cederbaum A.I. Inhibition of rat and human cytochrome P4502E1 catalytic activity and reactive oxygen radical formation by nitric oxide. Arch. Biochem. Biophys. 1997, 337:239-250.
39. Glasgow W.C., Hui R., Everhart A.L., Jayawickreme S.P., Angerman-Stewart J., Han B.B., Eling T.E. The linoleic acid metabolite, (13S)-hydroperoxyoctadecadienoic acid, augments the epidermal growth factor receptor signaling pathway by attenuation of receptor dephosphorylation. Differential response in Syrian hamster embryo tumor suppressor phenotypes. J. Biol. Chem. 1997, 272:19269-19276.
40. Goodwin D.C., Gunther M.R., Hsi L.C., Crews B.C., Eling T.E., Mason R.P., Marnett L.J. Nitric oxide trapping of tyrosyl radicals generated during prostaglandin endoperoxide synthase turnover. Detection of the radical derivative of tyrosine 385. J. Biol. Chem. 1998, 273:8903-8909.
41. Gryglewski R.J., Palmer R.M., Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986, 320:454-456.
42. Gunther M.R., Hsi L.C., Curtis J.F., Gierse J.K., Marnett L.J., Eling T.E., Mason R.P. Nitric oxide trapping of the tyrosyl radical of prostaglandin H synthase-2 leads to tyrosine iminoxyl radical and nitrotyrosine formation. J. Biol. Chem. 1997, 272:17086-17090.
43. Habib A., Bernard C., Lebret M., Creminon C., Esposito B., Tedgui A., Maclouf J. Regulation of the expression of cyclooxygenase-2 by nitric oxide in rat peritoneal macrophages. J. Immunol. 1997, 158:3845-3851.
44. Harder D.R., Lange A.R., Gebremedhin D., Birks E.K., Roman R.J. Cytochrome P450 metabolites of arachidonic acid as intracellular signaling molecules in vascular tissue. J. Vasc. Res. 1997, 34:237-243.
45. Haurand M., Ullrich V. Isolation and characterization of thromboxane synthase from human platelets as a cytochrome P-450 enzyme. J. Biol. Chem. 1985, 260:15059-15067.
46. Hayden M.S., Ghosh S. Shared principles in NF-kappaB signaling. Cell 2008, 132:344-362.
47. Hiltunen T., Luoma J., Nikkari T., Yla-Herttuala S. Induction of 15-lipoxygenase mRNA and protein in early atherosclerotic lesions. Circulation 1995, 92:3297-3303.
48. Hiltunen T.P., Luoma J.S., Nikkari T., Yla-Herttuala S. Expression of LDL receptor, VLDL receptor, LDL receptor-related protein, and scavenger receptor in rabbit atherosclerotic lesions: marked induction of scavenger receptor and VLDL receptor expression during lesion development. Circulation 1998, 97:1079-1086.
49. Holzhutter H.G., Wiesner R., Rathmann J., Stosser R., Kuhn H. A kinetic model for the interaction of nitric oxide with a mammalian lipoxygenase. Eur. J. Biochem. 1997, 245:608-616.
50. Hrycay E.G., O'Brien P.J. Cytochrome P-450 as a microsomal peroxidase utilizing a lipid peroxide substrate. Arch. Biochem. Biophys. 1971, 147:14-27.
51. Hsi L.C., Wilson L.C., Eling T.E. Opposing effects of 15-lipoxygenase-1 and -2 metabolites on MAPK signaling in prostate. Alteration in peroxisome proliferator-activated receptor gamma. J. Biol. Chem. 2002, 277:40549-40556.
52. Ignarro L.J. Haem-dependent activation of cytosolic guanylate cyclase by nitric oxide: a widespread signal transduction mechanism. Biochem. Soc. Trans. 1992, 20:465-469.
53. Ignarro L.J., Buga G.M., Wood K.S., Byrns R.E., Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. USA 1987, 84:9265-9269.
54. Ignarro L.J., Byrns R.E., Buga G.M., Wood K.S. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ. Res. 1987, 61:866-879.
55. Iles K.E., Wright M.M., Cole M.P., Welty N.E., Ware L.B., Matthay M.A., Schopfer F.J., Baker P.R., Agarwal A., Freeman B.A. Fatty acid transduction of nitric oxide signaling: nitrolinoleic acid mediates protective effects through regulation of the ERK pathway. Free Radic. Biol. Med. 2008, 46:866-875.
56. Itoh T., Fairall L., Amin K., Inaba Y., Szanto A., Balint B.L., Nagy L., Yamamoto K., Schwabe J.W. Structural basis for the activation of PPARgamma by oxidized fatty acids. Nat. Struct. Mol. Biol. 2008, 15:924-931.
57. Johnson G.L., Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002, 298:1911-1912.
58. Juncos L.A., Garvin J., Carretero O.A., Ito S. Flow modulates myogenic responses in isolated microperfused rabbit afferent arterioles via endothelium-derived nitric oxide. J. Clin. Invest. 1995, 95:2741-2748.
59. Kanner J., Harel S., Granit R. Nitric oxide, an inhibitor of lipid oxidation by lipoxygenase, cyclooxygenase and hemoglobin. Lipids 1992, 27:46-49.
60. Kensler T.W., Wakabayashi N., Biswal S. Cell Survival Responses to Environmental Stresses Via the Keap1-Nrf2-ARE Pathway. Annu. Rev. Pharmacol. Toxicol. 2007, 47:89-116.
61. Kiningham K.K., Daosukho C., St Clair D.K. IkBa (inhibitory kBa) identified as labile repressor of MnSOD (manganese superoxide dismutase) expression. Biochem. J. 2004, 384:543-549.
62. Kuhn H., Borchert A. Regulation of enzymatic lipid peroxidation: the interplay of peroxidizing and peroxide reducing enzymes. Free Radic. Biol. Med. 2002, 33:154-172.
63. Kuhn H., Belkner J., Zaiss S., Fahrenklemper T., Wohlfeil S. Involvement of 15-lipoxygenase in early stages of atherogenesis. J. Exp. Med. 1994, 179:1903-1911.
64. Kuhn H., Heydeck D., Hugou I., Gniwotta C. In vivo action of 15-lipoxygenase in early stages of human atherogenesis. J. Clin. Invest. 1997, 99:888-893.
65. Kuo L., Chilian W.M., Davis M.J. Coronary arteriolar myogenic response is independent of endothelium. Circ. Res. 1990, 66:860-866.
66. Kurumbail R.G., Kiefer J.R., Marnett L.J. Cyclooxygenase enzymes: catalysis and inhibition. Curr. Opin. Struct. Biol. 2001, 11:752-760.
67. Lancaster J.R. Nitroxidative, nitrosative, and nitrative stress: kinetic predictions of reactive nitrogen species chemistry under biological conditions. Chem. Res. Toxicol. 2006, 19:1160-1174.
68. Landino L.M., Crews B.C., Gierse J.K., Hauser S.D., Marnett L.J. Mutational analysis of the role of the distal histidine and glutamine residues of prostaglandin-endoperoxide synthase-2 in peroxidase catalysis, hydroperoxide reduction, and cyclooxygenase activation. J. Biol. Chem. 1997, 272:21565-21574.
69. Landino L.M., Crews B.C., Timmons M.D., Morrow J.D., Marnett L.J. Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis. Proc. Natl. Acad. Sci. USA 1996, 93:15069-15074.
70. Li D., Belusa R., Nowicki S., Aperia A. Arachidonic acid metabolic pathways regulating activity of renal Na(+)-K(+)-ATPase are age dependent. Am. J. Physiol. Renal. Physiol. 2000, 278:F823-F829.
71. Li Y., Zhang J., Schopfer F.J., Martynowski D., Garcia-Barrio M.T., Kovach A., Suino-Powell K., Baker P.R., Freeman B.A., Chen Y.E., Xu H.E. Molecular recognition of nitrated fatty acids by PPAR gamma. Nat. Struct. Mol. Biol. 2008, 15:865-867.
72. Lim D.G., Sweeney S., Bloodsworth A., White C.R., Chumley P.H., Krishna N.R., Schopfer F.J., O'Donnell V.B., Eiserich J.P., Freeman B.A. Nitrolinoleate, a nitric oxide-derived mediator of cell function: synthesis, characterization, and vasomotor activity. Proc. Natl. Acad. Sci. USA 2002, 99:15941-15946.
73. Lima E.S., Bonini M.G., Augusto O., Barbeiro H.V., Souza H.P., Abdalla D.S. Nitrated lipids decompose to nitric oxide and lipid radicals and cause vasorelaxation. Free Radic. Biol. Med. 2005, 39:532-539.
74. Lincoln T.M., Cornwell T.L. Intracellular cyclic GMP receptor proteins. FASEB J. 1993, 7:328-338.
75. Liu Y., Harder D.R., Lombard J.H. Myogenic activation of canine small renal arteries after nonchemical removal of the endothelium. Am. J. Physiol. 1994, 267:H302-H307.
76. Lopez B., Moreno C., Salom M.G., Roman R.J., Fenoy F.J. Role of guanylyl cyclase and cytochrome P-450 on renal response to nitric oxide. Am. J. Physiol. Renal. Physiol. 2001, 281:F420-F427.
77. Lu F., Zander D.S., Visner G.A. Increased expression of heme oxygenase-1 in human lung transplantation. J. Heart Lung Transplant. 2002, 21:1120-1126.
78. Marla S.S., Lee J., Groves J.T. Peroxynitrite rapidly permeates phospholipid membranes. Proc. Natl. Acad. Sci. USA 1997, 94:14243-14248.
79. Marnett L.J., Rowlinson S.W., Goodwin D.C., Kalgutkar A.S., Lanzo C.A. Arachidonic acid oxygenation by COX-1 and COX-2. Mechanisms of catalysis and inhibition. J. Biol. Chem. 1999, 274:22903-22906.
80. Marnett L.J., Wright T.L., Crews B.C., Tannenbaum S.R., Morrow J.D. Regulation of prostaglandin biosynthesis by nitric oxide is revealed by targeted deletion of inducible nitric-oxide synthase. J. Biol. Chem. 2000, 275:13427-13430.
81. Marnett L.J., Wright T.L., Crews B.C., Tannenbaum S.R., Morrow J.D. Regulation of prostaglandin biosynthesis by nitric oxide is revealed by targeted deletion of inducible nitric-oxide synthase. J. Biol. Chem. 2000, 275:13427-13430.
82. Matevossian E., Novotny A., Knebel C., Brill T., Werner M., Sinicina I., Kriner M., Stangl M., Thorban S., Huser N. The effect of selective inhibition of inducible nitric oxide synthase on cytochrome P450 after liver transplantation in a rat model. Transplant. Proc. 2008, 40:983-985.
83. McCarron J.G., Osol G., Halpern W. Myogenic responses are independent of the endothelium in rat pressurized posterior cerebral arteries. Blood Vessels 1989, 26:315-319.
84. Minamiyama Y., Takemura S., Imaoka S., Funae Y., Tanimoto Y., Inoue M. Irreversible inhibition of cytochrome P450 by nitric oxide. J. Pharmacol. Exp. Ther. 1997, 283:1479-1485.
85. Minghetti L., Polazzi E., Nicolini A., Creminon C., Levi G. Interferon-gamma and nitric oxide down-regulate lipopolysaccharide-induced prostanoid production in cultured rat microglial cells by inhibiting cyclooxygenase-2 expression. J. Neurochem. 1996, 66:1963-1970.
86. Mollace V., Muscoli C., Masini E., Cuzzocrea S., Salvemini D. Modulation of prostaglandin biosynthesis by nitric oxide and nitric oxide donors. Pharmacol. Rev. 2005, 57:217-252.
87. Moller M., Botti H., Batthyany C., Rubbo H., Radi R., Denicola A. Direct measurement of nitric oxide and oxygen partitioning into liposomes and low density lipoprotein. J. Biol. Chem. 2005, 280:8850-8854.
88. Moon T.C., Befus A.D. Exogenous nitric oxide regulates cyclooxygenase-2 expression and prostaglandin D(2) generation through p38 MAPK in mouse bone marrow-derived mast cells. Free Radic. Biol. Med. 2008, 45:780-788.
89. Muller C.M., Scierka A., Stiller R.L., Kim Y.M., Cook D.R., Lancaster J.R., Buffington C.W., Watkins W.D. Nitric oxide mediates hepatic cytochrome P450 dysfunction induced by endotoxin. Anesthesiology 1996, 84:1435-1442.
90. Murad F. The nitric oxide-cyclic GMP signal transduction system for intracellular and intercellular communication. Recent Prog. Horm. Res. 1994, 49:239-248.
91. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986, 74:1124-1136.
92. Nadtochiy S.M., Baker P.R., Freeman B.A., Brookes P.S. Mitochondrial nitroalkene formation and mild uncoupling in ischaemic preconditioning: implications for cardioprotection. Cardiovasc. Res. 2009, 82:333-340.
93. Nakatsuka M., Osawa Y. Selective inhibition of the 12-lipoxygenase pathway of arachidonic acid metabolism by L-arginine or sodium nitroprusside in intact human platelets. Biochem. Biophys. Res. Commun. 1994, 200:1630-1634.
94. Napolitano A., Camera E., Picardo M., d'Ischia M. Acid-promoted reactions of ethyl linoleate with nitrite ions: formation and structural characterization of isomeric nitroalkane, nitrohydroxy, and novel 3-nitro-1,5-hexadiene and 1,5-dinitro-1,3-pentadiene products. J. Org. Chem. 2000, 65:4853-4860.
95. Napolitano A., Camera E., Picardo M., d'Ishida M. Reactions of hydro(pero)xy derivatives of polyunsaturated fatty acids/esters with nitrite ions under acidic conditions. Unusual nitrosative breakdown of methyl 13-hydro(pero)xyoctadeca-9,11-dienoate to a novel 4-nitro-2-oximinoalk-3-enal product. J. Org. Chem. 2002, 67:1125-1132.
96. Napolitano A., Panzella L., Savarese M., Sacchi R., Giudicianni I., Paolillo L., d'Ischia M. Acid-induced structural modifications of unsaturated Fatty acids and phenolic olive oil constituents by nitrite ions: a chemical assessment. Chem. Res. Toxicol. 2004, 17:1329-1337.
97. Nelson M.J. The nitric oxide complex of ferrous soybean lipoxygenase-1. Substrate, pH, and ethanol effects on the active-site iron. J. Biol. Chem. 1987, 262:12137-12142.
98. Neuzil J., Upston J.M., Witting P.K., Scott K.F., Stocker R. Secretory phospholipase A2 and lipoprotein lipase enhance 15-lipoxygenase-induced enzymic and nonenzymic lipid peroxidation in low-density lipoproteins. Biochemistry 1998, 37:9203-9210.
99. Nie D., Tang K., Diglio C., Honn K.V. Eicosanoid regulation of angiogenesis: role of endothelial arachidonate 12-lipoxygenase. Blood 2000, 95:2304-2311.
100. Nowicki S., Chen S.L., Aizman O., Cheng X.J., Li D., Nowicki C., Nairn A., Greengard P., Aperia A. 20-Hydroxyeicosa-tetraenoic acid (20 HETE) activates protein kinase C. Role in regulation of rat renal Na+,K+-ATPase. J. Clin. Invest. 1997, 99:1224-1230.
101. Nyby M.D., Sasaki M., Ideguchi Y., Wynne H.E., Hori M.T., Berger M.E., Golub M.S., Brickman A.S., Tuck M.L. Platelet lipoxygenase inhibitors attenuate thrombin- and thromboxane mimetic-induced intracellular calcium mobilization and platelet aggregation. J. Pharmacol. Exp. Ther. 1996, 278:503-509.
102. O'Donnell V.B., Freeman B.A. Interactions between nitric oxide and lipid oxidation pathways: implications for vascular disease. Circ. Res. 2001, 88:12-21.
103. O'Donnell V.B., Chumley P.H., Hogg N., Bloodsworth A., Darley-Usmar V.M., Freeman B.A. Nitric oxide inhibition of lipid peroxidation: kinetics of reaction with lipid peroxyl radicals and comparison with alpha-tocopherol. Biochemistry 1997, 36:15216-15223.
104. O'Donnell V.B., Chumley P.H., Hogg N., Bloodsworth A., Darley-Usmar V.M., Freeman B.A. Nitric oxide inhibition of lipid peroxidation: kinetics of reaction with lipid peroxyl radicals and comparison with alpha-tocopherol. Biochemistry 1997, 36:15216-15223.
105. O'Donnell V.B., Coles B., Lewis M.J., Crews B.C., Marnett L.J., Freeman B.A. Catalytic consumption of nitric oxide by prostaglandin H synthase-1 regulates platelet function. J. Biol. Chem. 2000, 275:38239-38244.
106. O'Donnell V.B., Eiserich J.P., Chumley P.H., Jablonsky M.J., Krishna N.R., Kirk M., Barnes S., Darley-Usmar V.M., Freeman B.A. Nitration of unsaturated fatty acids by nitric oxide-derived reactive nitrogen species peroxynitrite, nitrous acid, nitrogen dioxide, and nitronium ion. Chem. Res. Toxicol. 1999, 12:83-92.
107. O'Donnell V.B., Taylor K.B., Parthasarathy S., Kuhn H., Koesling D., Friebe A., Bloodsworth A., Darley-Usmar V.M., Freeman B.A. 15-Lipoxygenase catalytically consumes nitric oxide and impairs activation of guanylate cyclase. J. Biol. Chem. 1999, 274:20083-20091.
108. Pacher P., Beckman J.S., Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 2007, 87:315-424.
109. Palmer R.M., Ferrige A.G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987, 327:524-526.
110. Pearson G., Robinson F., Beers Gibson T., Xu B.E., Karandikar M., Berman K., Cobb M.H. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 2001, 22:153-183.
111. Pfeiffer S., Gorren A.C., Schmidt K., Werner E.R., Hansert B., Bohle D.S., Mayer B. Metabolic fate of peroxynitrite in aqueous solution. Reaction with nitric oxide and pH-dependent decomposition to nitrite and oxygen in a 2:1 stoichiometry. J. Biol. Chem. 1997, 272:3465-3470.
112. Quilley J., McGiff J.C. Is EDHF an epoxyeicosatrienoic acid?. Trends Pharmacol. Sci. 2000, 21:121-124.
113. Rachakonda G., Xiong Y., Sekhar K.R., Stamer S.L., Liebler D.C., Freeman M.L. Covalent modification at Cys151 dissociates the electrophile sensor Keap1 from the ubiquitin ligase CUL3. Chem. Res. Toxicol. 2008, 21:705-710.
114. Radi R., Beckman J.S., Bush K.M., Freeman B.A. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J. Biol. Chem. 1991, 266:4244-4250.
115. Radi R., Denicola A., Freeman B.A. Peroxynitrite reactions with carbon dioxide-bicarbonate. Methods Enzymol. 1999, 301:353-367.
116. Rosolowsky M., Campbell W.B. Synthesis of hydroxyeicosatetraenoic (HETEs) and epoxyeicosatrienoic acids (EETs) by cultured bovine coronary artery endothelial cells. Biochim. Biophys. Acta. 1996, 1299:267-277.
117. Rouzer C.A., Marnett L.J. Mechanism of free radical oxygenation of polyunsaturated fatty acids by cyclooxygenases. Chem. Rev. 2003, 103:2239-2304.
118. Rubbo H., O'Donnell V. Nitric oxide, peroxynitrite and lipoxygenase in atherogenesis: mechanistic insights. Toxicology 2005, 208:305-317.
119. Rubbo H., Parthasarathy S., Barnes S., Kirk M., Kalyanaraman B., Freeman B.A. Nitric oxide inhibition of lipoxygenase-dependent liposome and low-density lipoprotein oxidation: termination of radical chain propagation reactions and formation of nitrogen-containing oxidized lipid derivatives. Arch. Biochem. Biophys. 1995, 324:15-25.
120. Rubbo H., Trostchansky A., O'Donnell V.B. Peroxynitrite-mediated lipid oxidation and nitration: mechanisms and consequences. Arch. Biochem. Biophys. 2009, 484:167-172.
121. Rudolph V., Schopfer F.J., Khoo N.K., Rudolph T.K., Cole M.P., Woodcock S.R., Bonacci G., Groeger A.L., Golin-Bisello F., Chen C.S., Baker P.R., Freeman B.A. Nitro-fatty acid metabolome: saturation, desaturation, b-oxidation, and protein adduction. J. Biol. Chem. 2009, 284:1461-1473.
122. Salerno J.C., Siedow J.N. The nature of the nitric oxide complexes of lipoxygenase. Biochim. Biophys. Acta. 1979, 579:246-251.
123. Salvemini D., Manning P.T., Zweifel B.S., Seibert K., Connor J., Currie M.G., Needleman P., Masferrer J.L. Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors. J. Clin. Invest. 1995, 96:301-308.
124. Salvemini D., Misko T.P., Masferrer J.L., Seibert K., Currie M.G., Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc. Natl. Acad. Sci. USA 1993, 90:7240-7244.
125. Salvemini D., Seibert K., Masferrer J.L., Misko T.P., Currie M.G., Needleman P. Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation. J. Clin. Invest. 1994, 93:1940-1947.
126. Salvemini D., Settle S.L., Masferrer J.L., Seibert K., Currie M.G., Needleman P. Regulation of prostaglandin production by nitric oxide; an in vivo analysis. Br. J. Pharmacol. 1995, 114:1171-1178.
127. Salvemini D., Wang Z.Q., Wyatt P.S., Bourdon D.M., Marino M.H., Manning P.T., Currie M.G. Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation. Br. J. Pharmacol. 1996, 118:829-838.
128. Scheidegger K.J., Butler S., Witztum J.L. Angiotensin II increases macrophage-mediated modification of low density lipoprotein via a lipoxygenase-dependent pathway. J. Biol. Chem. 1997, 272:21609-21615.
129. Schopfer F.J., Baker P.R., Giles G., Chumley P., Batthyany C., Crawford J., Patel R.P., Hogg N., Branchaud B.P., Lancaster J.R., Freeman B.A. Fatty acid transduction of nitric oxide signaling. Nitrolinoleic acid is a hydrophobically stabilized nitric oxide donor. J. Biol. Chem. 2005, 280:19289-19297.
130. Schopfer F.J., Batthyany C., Baker P.R., Bonacci G., Cole M.P., Rudolph V., Groeger A., Rudolph T.K., Nadtochiy S., Brookes P.S., Freeman B.A. Detection and quantification of protein adduction by electrophilic fatty acids: mitochondrial generation of fatty acid nitroalkene derivatives. Free Radic. Biol. Med. 2009, 46:1250-1259.
131. Schopfer F.J., Lin Y., Baker P.R., Cui T., Garcia-Barrio M., Zhang J., Chen K., Chen Y.E., Freeman B.A. Nitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor gamma ligand. Proc. Natl. Acad. Sci. USA 2005, 102:2340-2345.
132. Schwartzman M., Ferreri N.R., Carroll M.A., Songu-Mize E., McGiff J.C. Renal cytochrome P450-related arachidonate metabolite inhibits (Na++K+)ATPase. Nature 1985, 314:620-622.
133. Sendobry S.M., Cornicelli J.A., Welch K., Bocan T., Tait B., Trivedi B.K., Colbry N., Dyer R.D., Feinmark S.J., Daugherty A. Attenuation of diet-induced atherosclerosis in rabbits with a highly selective 15-lipoxygenase inhibitor lacking significant antioxidant properties. Br. J. Pharmacol. 1997, 120:1199-1206.
134. Sigari F., Lee C., Witztum J.L., Reaven P.D. Fibroblasts that overexpress 15-lipoxygenase generate bioactive and minimally modified LDL. Arterioscler. Thromb. Vasc. Biol. 1997, 17:3639-3645.
135. Stadler J., Harbrecht B.G., Di Silvio M., Curran R.D., Jordan M.L., Simmons R.L., Billiar T.R. Endogenous nitric oxide inhibits the synthesis of cyclooxygenase products and interleukin-6 by rat Kupffer cells. J. Leukoc. Biol. 1993, 53:165-172.
136. Stadler J., Trockfeld J., Schmalix W.A., Brill T., Siewert J.R., Greim H., Doehmer J. Inhibition of cytochromes P4501A by nitric oxide. Proc. Natl. Acad. Sci. USA 1994, 91:3559-3563.
137. Sun C.W., Alonso-Galicia M., Taheri M.R., Falck J.R., Harder D.R., Roman R.J. Nitric oxide-20-hydroxyeicosatetraenoic acid interaction in the regulation of K+ channel activity and vascular tone in renal arterioles. Circ. Res. 1998, 83:1069-1079.
138. Sun C.W., Falck J.R., Okamoto H., Harder D.R., Roman R.J. Role of cGMP versus 20-HETE in the vasodilator response to nitric oxide in rat cerebral arteries. Am. J. Physiol. Heart Circ. Physiol. 2000, 279:H339-H350.
139. Suzuki H., Tashiro S., Sun J., Doi H., Satomi S., Igarashi K. Cadmium induces nuclear export of Bach1, a transcriptional repressor of heme oxygenase-1 gene. J. Biol. Chem. 2003, 278:49246-49253.
140. Swierkosz T.A., Mitchell J.A., Warner T.D., Botting R.M., Vane J.R. Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids. Br. J. Pharmacol. 1995, 114:1335-1342.
141. Tak P.P., Firestein G.S. NF-kappaB: a key role in inflammatory diseases. J. Clin. Invest. 2001, 107:7-11.
142. Takemura S., Minamiyama Y., Imaoka S., Funae Y., Hirohashi K., Inoue M., Kinoshita H. Hepatic cytochrome P450 is directly inactivated by nitric oxide, not by inflammatory cytokines, in the early phase of endotoxemia. J. Hepatol. 1999, 30:1035-1044.
143. Tapuria N., Kumar Y., Habib M.M., Abu Amara M., Seifalian A.M., Davidson B.R. Remote ischemic preconditioning: a novel protective method from ischemia reperfusion injury--a review. J. Surg. Res. 2008, 150:304-330.
144. Thomas D.D., Miranda K.M., Colton C.A., Citrin D., Espey M.G., Wink D.A. Heme proteins and nitric oxide (NO): the neglected, eloquent chemistry in NO redox signaling and regulation. Antioxid. Redox. Signal. 2003, 5:307-317.
145. Torres M., Forman H.J. Redox signaling and the MAP kinase pathways. Biofactors 2003, 17:287-296.
146. Traylor T.G., Sharma V.S. Why NO?. Biochemistry 1992, 31:2847-2849.
147. Trostchansky A., Rubbo H. Nitrated fatty acids: mechanisms of formation, chemical characterization, and biological properties. Free Radic. Biol. Med. 2008, 44:1887-1896.
148. Tsai A.L., Wei C., Kulmacz R.J. Interaction between nitric oxide and prostaglandin H synthase. Arch. Biochem. Biophys. 1994, 313:367-372.
149. Tsikas D., Zoerner A., Mitschke A., Homsi Y., Gutzki F.M., Jordan J. Specific GC-MS/MS stable-isotope dilution methodology for free 9- and 10-nitro-oleic acid in human plasma challenges previous LC-MS/MS reports. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 2009, 877:2895-2908.
150. Tunctan B., Yaghini F.A., Estes A., Malik K.U. Inhibition by nitric oxide of cytochrome P450 4A activity contributes to endotoxin-induced hypotension in rats. Nitric Oxide 2006, 14:51-57.
151. Tunctan B., Yaghini F.A., Estes A., Malik K.U. Prostaglandins inhibit cytochrome P450 4A activity and contribute to endotoxin-induced hypotension in rats via nitric oxide production. Arch. Pharm. Res. 2008, 31:856-865.
152. Vane J.R., Mitchell J.A., Appleton I., Tomlinson A., Bishop-Bailey D., Croxtall J., Willoughby D.A. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc. Natl. Acad. Sci. USA 1994, 91:2046-2050.
153. VanRollins M., Kaduce T.L., Fang X., Knapp H.R., Spector A.A. Arachidonic acid diols produced by cytochrome P-450 monooxygenases are incorporated into phospholipids of vascular endothelial cells. J. Biol. Chem. 1996, 271:14001-14009.
154. VanRollins M., Kaduce T.L., Knapp H.R., Spector A.A. 14,15-Epoxyeicosatrienoic acid metabolism in endothelial cells. J. Lipid. Res. 1993, 34:1931-1942.
155. Villacorta L., Zhang J., Garcia-Barrio M., Chen X., Freeman B.A., Chen Y.E., Cui T. Nitro-linoleic Acid Inhibits Vascular Smooth Muscle Cell Proliferation via the Keap1/Nrf2 Signaling Pathway. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H770-H776.
156. Wade M.L., Fitzpatrick F.A. Nitric oxide modulates the activity of the hemoproteins prostaglandin I2 synthase and thromboxane A2 synthase. Arch. Biochem. Biophys. 1997, 347:174-180.
157. Weintraub N.L., Fang X., Kaduce T.L., VanRollins M., Chatterjee P., Spector A.A. Potentiation of endothelium-dependent relaxation by epoxyeicosatrienoic acids. Circ Res. 1997, 81:258-267.
158. Wiesner R., Rathmann J., Holzhutter H.G., Stosser R., Mader K., Nolting H., Kuhn H. Nitric oxide oxidises a ferrous mammalian lipoxygenase to a pre-activated ferric species. FEBS Lett. 1996, 389:229-232.
159. Wink D.A., Mitchell J.B. Chemical biology of nitric oxide: insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic. Biol. Med. 1998, 25:434-456.
160. Wink D.A., Osawa Y., Darbyshire J.F., Jones C.R., Eshenaur S.C., Nims R.W. Inhibition of cytochromes P450 by nitric oxide and a nitric oxide-releasing agent. Arch. Biochem. Biophys. 1993, 300:115-123.
161. Wittwer J., Hersberger M. The two faces of the 15-lipoxygenase in atherosclerosis. Prostaglandins Leukot Essent Fatty Acids 2007, 77:67-77.
162. Wright M.M., Schopfer F.J., Baker P.R., Vidyasagar V., Powell P., Chumley P., Iles K.E., Freeman B.A., Agarwal A. Fatty acid transduction of nitric oxide signaling: nitrolinoleic acid potently activates endothelial heme oxygenase 1 expression. Proc. Natl. Acad. Sci. USA 2006, 103:4299-4304.
163. Wu S., Chen W., Murphy E., Gabel S., Tomer K.B., Foley J., Steenbergen C., Falck J.R., Moomaw C.R., Zeldin D.C. Molecular cloning, expression, and functional significance of a cytochrome P450 highly expressed in rat heart myocytes. J. Biol. Chem. 1997, 272:12551-12559.
164. Xu W., Takahashi Y., Iwasaki T., Hattori H., Yoshimoto T. LDL receptor-related protein plays an essential role in 12/15-lipoxygenase-mediated LDL oxidation by macrophages. Adv. Exp. Med. Biol. 2003, 525:181-184.
165. Yla-Herttuala S., Rosenfeld M.E., Parthasarathy S., Glass C.K., Sigal E., Witztum J.L., Steinberg D. Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions. Proc. Natl. Acad. Sci. USA 1990, 87:6959-6963.
166. Yla-Herttuala S., Rosenfeld M.E., Parthasarathy S., Sigal E., Sarkioja T., Witztum J.L., Steinberg D. Gene expression in macrophage-rich human atherosclerotic lesions. 15-lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid- protein adducts. J. Clin. Invest. 1991, 87:1146-1152.
167. Zhou J., Zhu X., Zhang G., Ling T. Protective effect of hemoglobin-induced heme oxygenase-1 on injured lungs caused by limb ischemia-reperfusion in rats. Chin. J. Traumatol. 2002, 5:86-91.
168. Zhu H., Takahashi Y., Xu W., Kawajiri H., Murakami T., Yamamoto M., Iseki S., Iwasaki T., Hattori H., Yoshimoto T. Low density lipoprotein receptor-related protein-mediated membrane translocation of 12/15-lipoxygenase is required for oxidation of low density lipoprotein by macrophages. J. Biol. Chem. 2003, 278:13350-13355.
169. Zhu Y., Schieber E.B., McGiff J.C., Balazy M. Identification of arachidonate P-450 metabolites in human platelet phospholipids. Hypertension 1995, 25:854-859.
170. Zou M.H., Ullrich V. Peroxynitrite formed by simultaneous generation of nitric oxide and superoxide selectively inhibits bovine aortic prostacyclin synthase. FEBS Lett. 1996, 382:101-104.